Q: Why does QIPT keep hitting 52 week lows? Their recent earnings appeared to be decent. Is it time to sell this one?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Could you provide the forward earnings estimated for 2024 and the broken down in quarters.
thanks
thanks
Q: Hi 5i, trying to find a rose amongst thorns, and given the change in inclusion rates due to the budget, wouldn't this accelerate any deals in the pipeline? Not trying to be political.
#16Months2GO
#16Months2GO
Q: Hi Team,
Can I please have your comments on UNH's recent earnings. Also is it now a buy, sell or hold and your rationales?
Thanks
Harry
Can I please have your comments on UNH's recent earnings. Also is it now a buy, sell or hold and your rationales?
Thanks
Harry
Q: It is good to see WELL make an acquisition. How significant is this deal ?
Q: When do they report first quarter results?
-
WELL Health Technologies Corp. (WELL $4.27)
-
HealWELL AI Inc. Class A Subordinate Voting Shares (AIDX $0.95)
Q: Healwell is tremendously appreciating in share price. How does Well health tech. benefit from this. I don't know if they have an investment, part ownership or if its just a collaboration.
Thanks Steve
Thanks Steve
Q: They have the only non invasive basal cell carcinoma treatment at the moment that is effective as a cure. They found this out after the phase 1 safety and tolerabiliy study. No side effects. Does this look like a good opportunity for investment even though it is very early in clinical trials. This kind of investment is usually high risk but it seems mitigated.
Q: Good morning,
Can you shed some light on Zoetis' decline this am?
Thank you.
Can you shed some light on Zoetis' decline this am?
Thank you.
Q: Please let me know your views on SIGA Technologies, many thanks.
Q: What is your view of Charles River Laboratories International Inc please, thanks.
Q: Gud seems to be on a bit of a run is there any recent news that your aware of for the new interest and would you change your opinion.
Q: I am attracted to long term holdings. Been watching WELL hammering on technical support of about $3.65 for weeks now. I'm thinking of pulling the trigger.
Looking at their growing revenue and P/S multiple, those numbers look quite good for a small cap. Is there a better metric for this particular company? What do you think is the biggest negative that investors see in this stock at the moment?
Looking at their growing revenue and P/S multiple, those numbers look quite good for a small cap. Is there a better metric for this particular company? What do you think is the biggest negative that investors see in this stock at the moment?
-
Pfizer Inc. (PFE $26.33)
-
UnitedHealth Group Incorporated (DE) (UNH $368.78)
-
Align Technology Inc. (ALGN $178.91)
-
Fulgent Genetics Inc. (FLGT $14.13)
Q: Hi 5i,
Looking to sell my position in FLGT for a loss in my non-reg account. Potentially looking to replace FLGT with PFE to maintain US/Health care exposure. Would appreciate you thoughts and if you believe there are better US health care stocks to consider.
Thank you in advance,
Greg C.
Looking to sell my position in FLGT for a loss in my non-reg account. Potentially looking to replace FLGT with PFE to maintain US/Health care exposure. Would appreciate you thoughts and if you believe there are better US health care stocks to consider.
Thank you in advance,
Greg C.
Q: CADL US based clinical stage drug company and would appreciate your thoughts on taking a small position
Thanks
Rick
Thanks
Rick
Q: I own HTL and hope you can provide your thoughts on the medium to long term prospects for this company. It seems to have peaked 2021/2022 and has since been in a downtrend, basing at approx. $1.30. I thought the ART business was very interesting so I purchased some awhile back. thanks
Q: can you give an up date. can they turn the corner? debt is high, would anybody buy this company ?
Q: I mean this looks far more serious than just the stock going lower for no apparent reason. Seems to me there's trouble in the henhouse. Should we be concerned?
"Mar. 10, 2023, The Capitol Forum reported that prior to Feb. 2023 InMode had not been submitting mandatory reports to the FDA regarding injuries and malfunctions stemming from the use of its devices. The report also observed "a search of personal injury lawsuits filed against InMode over the last several years indicates the company has been aware of dozens more alleged serious injuries that it never reported to the FDA."
Then, on Oct. 12, 2024 The Capitol Forum published another investigative report finding that "far from charging full price for its products, InMode heavily discounts almost every device it sells and expects sales representatives to discount devices anywhere from 16% and 40% off the 'list price[]'" and "[a]ccording to one former salesperson at InMode 'the price is basically whatever the customer can get financing for.'"
These events sent the price of InMode shares sharply lower."
"Mar. 10, 2023, The Capitol Forum reported that prior to Feb. 2023 InMode had not been submitting mandatory reports to the FDA regarding injuries and malfunctions stemming from the use of its devices. The report also observed "a search of personal injury lawsuits filed against InMode over the last several years indicates the company has been aware of dozens more alleged serious injuries that it never reported to the FDA."
Then, on Oct. 12, 2024 The Capitol Forum published another investigative report finding that "far from charging full price for its products, InMode heavily discounts almost every device it sells and expects sales representatives to discount devices anywhere from 16% and 40% off the 'list price[]'" and "[a]ccording to one former salesperson at InMode 'the price is basically whatever the customer can get financing for.'"
These events sent the price of InMode shares sharply lower."
-
Intuitive Surgical Inc. (ISRG $457.78)
-
AbbVie Inc. (ABBV $206.60)
-
Eli Lilly and Company (LLY $963.33)
-
Merck & Company Inc. (MRK $112.16)
-
UnitedHealth Group Incorporated (DE) (UNH $368.78)
-
TransMedics Group Inc. (TMDX $100.01)
Q: Further to Peter's column in the Financial Post [always good, plain ,common sense advice] I'm wondering what US companies in the health care sector might be considered?
Thanks
Thanks
Q: As a follow-up to my question last week about this company and based on the news this morning, has the answer changed in terms of it being fine to sell now versus still holding for a little while?